ANNELIESE HALE: Open Payments
NPI 1063963809 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 26 payments from 20 companies in 2025. Trend: 2023 $666 · 2024 $422 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $72 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Edwards Lifesciences Corporation | 1 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Boston Scientific Corporation | 1 | $36 |
| GlaxoSmithKline, LLC. | 1 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| IBSA Pharma Inc. | 1 | $22 |
| SANOFI-AVENTIS U.S. LLC | 1 | $22 |
| SANOFI PASTEUR INC. | 1 | $22 |
Products named: Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, WaveWriter Alpha Prime 16, SHINGRIX, LEQVIO, GVOKE HYPOPEN, Tirosint, TZIELD, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE.
Industry payments across CO — which companies pay providers there.
